Quantcast

Latest Transplantation medicine Stories

2014-03-06 08:30:30

DUBLIN, Ireland, March 6, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/hp66zf/organ) has announced the addition of the "Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019" [http://www.researchandmarkets.com/research/hp66zf/organ ] report to their offering. The rise in incidences of organ failure in kidney, liver and heart patients across the globe is augmenting the...

2014-03-04 16:25:29

WESTMINSTER, Colo., March 4, 2014 /PRNewswire/ -- Cerapedics, Inc., an orthobiologics company focused on developing and commercializing novel peptide enhanced bone graft products based on its proprietary synthetic small peptide (P-15) technology platform, announced today that preliminary outcomes data from the company's FDA Investigational Device Exemption (IDE) clinical trial for i-FACTOR(TM) Peptide Enhanced Bone Graft will be presented at the Canaccord Genuity Musculoskeletal...

2014-03-04 16:25:27

CENTENNIAL, Colo., March 4, 2014 /PRNewswire-USNewswire/ -- AlloSource (allosource.org), one of the nation's largest providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, announced the donation of bone allografts to surgeons from Cincinnati Children's Hospital Medical Center who traveled to India to perform free surgeries for children afflicted with spine and upper extremity deformities. The...

2014-03-03 16:24:51

LONDON, March 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: UK Orthopedic Devices Market Report, 2005 - 2018Short Description The Market Intelligence report provides critical market data for UK orthopedic devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital "cross...

2014-02-24 12:26:25

GRAPEVINE, Texas, Feb. 24, 2014 /PRNewswire-USNewswire/ -- Just 10 years ago, older patients were typically considered ineligible to receive a blood or bone marrow transplantation (BMT) to treat their blood cancer, but today, patients age 65 and older not only qualify for BMT therapy but are the fastest growing group of recipients. This was reported at the American Society for Blood and Marrow Transplantation (ASBMT) annual meeting as it celebrates its 20(th) anniversary and reflects...

2014-02-19 12:28:05

LUND, Sweden, Feb. 19, 2014 /PRNewswire/ -- BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced today the launch of a new registry to collect long term data of CERAMENT(TM)|G, the first injectable antibiotic eluting, osteoconductive, ceramic bone substitute indicated to promote and protect bone healing being jeopardized by infection. The registry is part of the company's...

2014-02-18 16:26:44

CENTENNIAL, Colo., Feb. 18, 2014 /PRNewswire-USNewswire/ -- Peter Stevens, the Vice President of Research & Development and Marketing at AlloSource (allosource.org), one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, has been named to the Advisory Board for the University of Denver's Professional Sciences Master's Program in Biomedical Sciences....

2014-02-18 09:01:07

A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes. In the Immune Tolerance Network's (ITN) HALT-MS study, 24 patients with relapsing, remitting multiple sclerosis received high-dose immunosuppression followed by a transplant of their own stem cells, called an autologous stem cell transplant, to potentially reprogram the immune system so that...

2014-02-18 08:32:06

NEWPORT BEACH, Calif., Feb. 18, 2014 /PRNewswire/ -- BioStructures, LLC, a privately held orthobiologics company, today announced that the United States Food and Drug Administration has granted 510(k) clearance for Bioactive Bone Graft Putty (Signafuse(TM)). Signafuse(TM) is indicated for the posterolateral spine, extremities and pelvis as well as a bone graft extender in the posterolateral spine. Signafuse(TM) represents a new class of synthetic biomaterials designed for...

2014-02-14 12:24:24

DUBLIN, February 14, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/n7sxmf/autologous_tissue) has announced the addition of the "Autologous Tissue Repair to 2018. Products, Indications, Markets and Forecasts" [http://www.researchandmarkets.com/research/n7sxmf/autologous_tissue ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The ability to isolate, purify and re-inject...


Latest Transplantation medicine Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »
Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related